Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Sep 28, 2015 12:19pm
189 Views
Post# 24141155

NPH a nice hedge as a pair trade with US bio-tech...

NPH a nice hedge as a pair trade with US bio-tech...I think NPH could be used by US funds and  Bio-tech investors as a pair trade on US bio tech stocks to reeduce risks... The Hillary tweet shocked the US bio-tech market and NPH seems to fill all the holes in the US bio-tech story risk... Firstly, Generics should do well compared to expensive brand drugs in times of greater political pressure on drug pricing.... Secondly, as Hillary came out and said recently, the Democrats under her , would like to leagalize Canadian on-line prescription services... The recent shock to US Bio-techs caused by this is fresh in all American Bio-Tech  fund managers and investors thinking......A great time to get the word out to them on NPH as both a pair trade hedge on US bio-tech, and also a stand alone investment..
Bullboard Posts